Products for Research Use Only
RegisterLogin

ASP3026

CAT: 0804-HY-13326-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13326-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ASP3026 is a selective and orally active inhibitor of anaplastic lymphoma kinase (ALK) . ASP3026 is a selective and oral active anaplastic lymphoma kinase (ALK) inhibitor with a IC50 value of 3.5 nM. ASP3026 can inhibit the phosphorylation of IGF-1R, STAT3, AKT and JNK proteins, and induce the cleavage of caspase 3 and PARP. It also inhibited ROS and ACK. ASP3026 can be used in anti-tumor research[1][2][3][4].
CAS Number
1097917-15-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Akt; Anaplastic lymphoma kinase (ALK) ; Apoptosis; Caspase; IGF-1R; JNK; PARP; ROS Kinase; STAT
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ASP3026.html
Purity
99.88
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
COC(C=C(N1CCC(N2CCN(C)CC2)CC1)C=C3)=C3NC4=NC=NC(NC5=C(S(C(C)C)(=O)=O)C=CC=C5)=N4
Molecular Formula
C29H40N8O3S
Molecular Weight
580.74
Precautions
H302, H315, H319, H335
References & Citations
[1]Discovery of Iikubo K, et, al. N-{2-Methoxy-4-[4- (4-methylpiperazin-1-yl) piperidin-1-yl]phenyl}-N'-[2- (propane-2-sulfonyl) phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor. Chem Pharm Bull (Tokyo) . 2018;66 (3) :251-262.|[2]George SK, et, al. The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget. 2014 Jul 30;5 (14) :5750-63.|[3]Bhuyan AAM, et, al. Inhibition of Erythrocyte Cell Membrane Scrambling by ASP3026. Cell Physiol Biochem. 2017;43 (2) :507-517.|[4]Mori M, et al. The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice. Mol Cancer Ther. 2014 Feb;13 (2) :329-40.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
Caspase 3; PARP1; STAT3

Related Products

CatalogName
HY-160888-01ASP8302
HY-125881ASP1126

Alternative Products

CatalogName
A3193-200ASP3026
A11773-200ASP3026 200mg
A11773-50ASP3026 50mg
A11773-25ASP3026 25mg
A11773-5ASP3026 5mg
A11773-100ASP3026 100mg
A11773-10ASP3026 10mg
A11773-10mM-DASP3026 10mM * 1mL in DMSO

Popular Products